Leaflet VIPERFAV concentrate for solution for infusion

Product code:
W66066001
Quantity:
1
Indicated for:
viper bite; envenomation
Route of administration:
infusion
Substance:
antivenom (therapeutic serum)
ATC
J06BB — Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Antivenom serum is a product derived from the plasma of animals (usually horses) immunized against viper venom. It is used to treat viper bites by neutralizing the toxic effects of the venom and preventing severe complications such as kidney failure, coagulopathy, shock, or tissue necrosis.

The antivenom serum is administered intravenously, typically in specialized medical facilities, under strict medical supervision. The dosage is determined based on the severity of the envenomation, the patient's symptoms, and the specific type of viper involved.

Side effects may include allergic reactions such as skin rashes, itching, fever, or, in rare cases, anaphylactic reactions. Serum sickness, a delayed reaction characterized by fever, joint pain, and skin rashes, may also occur days or weeks after administration.

Antivenom serum is a life-saving treatment in cases of severe envenomation, but its use requires careful monitoring to manage potential adverse effects. It is crucial for patients to seek immediate medical attention after a viper bite, and the serum should only be administered by qualified medical personnel.

General data about VIPERFAV

Substance:
antivenom
Product code:
W66066001
Pharmaceutical form:
concentrate for solution for infusion
Packing volume:
4ml
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
SANOFI PASTEUR - FRANTA
Holder:
C.N. UNIFARM S.A. - ROMANIA
Number:
432/2019/01
Shelf life:
2 years

Pharmaceutical forms available for antivenom

Concentrations available for antivenom

  • 500 UA/fiola
  • 500UA LD50/fiola